Pioglitazone and the secondary prevention of cardiovascular disease. A meta-analysis of randomized-controlled trials

Overview of attention for article published in Cardiovascular Diabetology, October 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (79th percentile)
Good Attention Score compared to outputs of the same age and source (69th percentile)

Mentioned by

twitter: 11 X users

wikipedia: 2 Wikipedia pages

Citations

dimensions_citation: 100 Dimensions

Readers on

mendeley: 77 Mendeley

Summary X Wikipedia Dimensions citations

So far, Altmetric has seen 15 X posts from 11 X users, with an upper bound of 39,347 followers.

RT @syuichiao89: Pioglitazone and the secondary prevention of cardiovascular disease. A meta-analysis of randomized-controlled trials. - Pu…

12 Nov 2019

Reply Repost Favourite

Pioglitazone and the secondary prevention of cardiovascular disease. A meta-analysis of randomized-controlled trials. - PubMed - NCBI https://t.co/nToRMYuUCB

12 Nov 2019

Reply Repost Favourite

RT @syuichiao89: Pioglitazone and the secondary prevention of cardiovascular disease. A meta-analysis of randomized-controlled trials https…

16 Apr 2018

Reply Repost Favourite

Pioglitazone and the secondary prevention of cardiovascular disease. A meta-analysis of randomized-controlled trials https://t.co/nmdq3sBmLZ

16 Apr 2018

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 11 additional X posts.